There is no such thing as "good enough" in the world of cancer care. As your practice strives to improve outcomes—while facing incredible cost pressures and increased competition—you need bold new tools and fresh thinking.
Accuray is coming to ASTRO 2017 ready to give you the confidence to drive positive and powerful change—for your patients and your practice.
Treatment Delivery System
© 2007 - 2017 Accuray Incorporated. All Rights Reserved. Accuray, the stylized logo, CyberKnife, TomoTherapy, Synchrony, Xsight, Xchange, TomoHD, Hi•Art, and RoboCouch are among the trademarks and / or registered trademarks of Accuray Incorporated in the United States and other countries.
Important Safety Statement: Most side effects of radiotherapy, including radiotherapy delivered with Accuray systems, are mild and temporary, often involving fatigue, nausea, and skin irritation. Side effects can be severe, however, leading to pain, alterations in normal body functions (for example, urinary or salivary function), deterioration of quality of life, permanent injury and even death.
Side effects can occur during or shortly after radiation treatment or in the months and years following radiation. The nature and severity of side effects depend on many factors, including the size and location of the treated tumor, the treatment technique (for example, the radiation dose), the patient's general medical condition, to name a few. For more details about the side effects of your radiation therapy, and if treatment with an Accuray product is right for you, ask your doctor.
See Accuray's latest improvements in action—and get an insider look at the transformative changes coming soon.
CONFIDENCE TO DRIVE INNOVATION IN STEREOTACTIC RADIATION THERAPYSunday, September 24th
12:15 pm - 1:15 pm
Topics & Presenters Include:
Clinical Experience with Breast Applications
Jonathan Haas, MD
Winthrop University Hospital
Prostate SBRT – Heterogeneous Dose Distribution: Rationale, Methods, Outcomes
and Future Direction: 2017 Update
Donald B. Fuller, MD
Genesis Healthcare Partners
Head and Neck Skull Base Stereotactic Radiotherapy Plan Comparison Study: Gamma Knife, CyberKnife®, Linac Photons, or Protons?
Jack Phan, MD, PhD
MD Anderson Cancer Center
INNOVATION FOR EVERY
Monday, September 25th
DAY, CONFIDENCE IN EVERY OUTCOME
12:30 pm - 1:30 pm
Topics & Presenters Include:
TomoTherapy versus RapidArc: Comparison
of Clinical Outcomes in Head & Neck Cancers
Jean-Emmanuel Bibault, MD, MSc
Georges-Pompidou European Hospital
Adaptive Replanning and Delivery
Verification with PreciseART™ on Radixact™
X. Allen Li, PhD, DABMP, FAAPM
Medical College of Wisconsin
UW Radixact™ Experience
John Bayouth, PhD
University of Wisconsin – Madison School
of Medicine and Public Health
Revolutionary insights and innovations that power positive outcomes.
Concise talks on real-world experiences and proven best practices. Topics include:
- Using the TomoTherapy® System for Whole Breast Irradiation in the Community Clinic Setting
- SBRT for Hepatobiliary and Pancreatic Cancers
- Dosimetric Verification of MLC-Collimated CyberKnife® Prostate Plans
- Advanced CyberKnife® Treatment Plans for Lung and Esophagus
- Mature Outcomes for CyberKnife® with Fiducial Tracking
- Oral Cancer Treatment with TomoHelical™ Treatment Delivery
- Transformative Capabilities of the Accuray Precision™ Treatment Planning System: Deformation, AutoSegmentation™, Adaptive Radiation Therapy and Retreatment Applications
- Feasibility of Real-Time Motion Management on the Radixact System
- CyberKnife® SBRT for Prostate Cancer
Learn more about landmark prospective multi-institutional clinical studies
that demonstrate the value of the CyberKnife®, TomoTherapy®
and Radixact™ Treatment Delivery Systems.